<?xml version="1.0" encoding="UTF-8"?>
<p>Our final sample consisted of 1160 patients (412 [35.5%] males, 748 [64.5%] females; 
 <xref rid="pntd.0008281.t001" ref-type="table">Table 1</xref>). Of those, 129 (11.12%) were children (&lt;15 years), 333 (28.7%) were adolescents or young adults (AYA; 15–29 years), 535 (46.12%) were adults (30–59 years) and 163 (14.05%) were 59 years or older (
 <xref rid="pntd.0008281.t001" ref-type="table">Table 1</xref>). Age ranged from 5 to 90 years old (mean age = 36.65, median age = 34, SD = 18.7). We found statistically significant differences in gender (
 <italic>P</italic>&lt;0.0001; 
 <xref rid="pntd.0008281.t001" ref-type="table">Table 1</xref>) and age group distributions (
 <italic>P</italic>&lt;0.0001; 
 <xref rid="pntd.0008281.t001" ref-type="table">Table 1</xref>). A significantly bigger proportion of CHIKV infected individuals inhabited low-income areas of the city, particularly areas near the border of the Magdalena river (east region)(
 <xref ref-type="fig" rid="pntd.0008281.g001">Fig 1A</xref>). Main symptoms were fever (present in 94% of patients), headache (73%), general discomfort (59%), neck (54%) and back pain (53%), maculopapular rash (51%), myalgia (38%), arthritis (29%), conjunctivitis (7%), and nausea/vomiting (24%/21%) (
 <xref rid="pntd.0008281.t002" ref-type="table">Table 2</xref>). Some patients manifested to be suffering from persistent joint pain for months, even years.
</p>
